AAAAAA
Results: 1-25/45
Authors:
Valderrabano, F
Golper, T
Muirhead, N
Ritz, E
Levin, A
Citation: F. Valderrabano et al., Chronic kidney disease: why is current management uncoordinated and suboptimal?, NEPH DIAL T, 16, 2001, pp. 61-64
Authors:
Valderrabano, F
Citation: F. Valderrabano, Building a healthier heart through early anaemia correction - Proceedings of a Technical Forum held at the 37th ERA-EDTA Congress - 19 September 2000- Nice, France - Introduction, NEPH DIAL T, 16, 2001, pp. 1-2
Authors:
Valderrabano, F
Citation: F. Valderrabano, Building A Healthier Heart Through Early Anaemia Correction - Proceedings of a Technical Forum held at the 37th ERA-EDTA Congress - 19 September 2000Nice, France - Concluding remarks, NEPH DIAL T, 16, 2001, pp. 19-20
Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis
Authors:
Goicoechea, M
Caramelo, C
Rodriguez, P
Verde, E
Gruss, E
Albalate, M
Ortiz, A
Casado, S
Valderrabano, F
Citation: M. Goicoechea et al., Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis, NEPH DIAL T, 16(11), 2001, pp. 2188-2193
Authors:
Carretero, D
Perez-Flores, I
de Vinuesa, SG
Luno, J
Valderrabano, F
Citation: D. Carretero et al., Acute renal failure after bacteraemia and endocarditis, NEPH DIAL T, 16(11), 2001, pp. 2265-2266
Authors:
Valderrabano, F
Luno, J
Egido, J
Diez, J
Citation: F. Valderrabano et al., Current aspects in the interplay between hypertension and the kidney - Introduction, NEPH DIAL T, 16, 2001, pp. 1-1
Authors:
Ridao, N
Luno, J
de Vinuesa, SG
Gomez, F
Tejedor, A
Valderrabano, F
Citation: N. Ridao et al., Prevalence of hypertension in renal disease, NEPH DIAL T, 16, 2001, pp. 70-73
Authors:
de Vinuesa, SG
Luno, J
Gomez-Campdera, F
Ridao, N
Sanchez, M
Dall'Anese, C
Valderrabano, F
Citation: Sg. De Vinuesa et al., Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs, NEPH DIAL T, 16, 2001, pp. 78-81
Authors:
Perez-Garcia, R
Lopez-Gomez, JM
Jofre, R
Junco, E
Valderrabano, F
Citation: R. Perez-garcia et al., Haemodialysis dose, extracellular volume control and arterial hypertension, NEPH DIAL T, 16, 2001, pp. 98-101
Authors:
Valderrabano, F
Jofre, R
Lopez-Gomez, JM
Citation: F. Valderrabano et al., Quality of life in end-stage renal disease patients, AM J KIDNEY, 38(3), 2001, pp. 443-464
Authors:
Campdera, FJG
Luno, J
de Vinuesa, SG
Valderrabano, F
Citation: Fjg. Campdera et al., Vascular access prior to dialysis - Is there evidence-based justification?, NEFROLOGIA, 21(3), 2001, pp. 321-322
Authors:
Carretero-Dios, D
Perez-Garcia, R
Rodriguez-Benitez, P
Villaverde, M
Gomez-Campdera, F
Valderrabano, F
Citation: D. Carretero-dios et al., Diabetes mellitus as a cause of end-stage renal disease. An epidemic in the XXIst century?, NEFROLOGIA, 21, 2001, pp. 83-87
Authors:
Campdera, FJG
Luno, J
de Vinuesa, MSG
Valderrabano, F
Citation: Fjg. Campdera et al., Criteria for recommending dialysis and a consideration of early deaths on renal replacement therapy, NEFROLOGIA, 21(2), 2001, pp. 218-220
Authors:
Moreno, F
Sanz-Guajardo, D
Lopez-Gomez, JM
Jofre, R
Valderrabano, F
Citation: F. Moreno et al., Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients, J AM S NEPH, 11(2), 2000, pp. 335-342
Authors:
Rodriguez-Benitez, P
Perez-Garcia, R
Arenas, J
Valderrabano, F
Citation: P. Rodriguez-benitez et al., L-carnitine in dialysis, more than a commercial affair, NEPH DIAL T, 15(9), 2000, pp. 1477-1478
Authors:
Locatelli, F
Valderrabano, F
Hoenich, N
Bommer, J
Leunissen, K
Cambi, V
Citation: F. Locatelli et al., Progress in dialysis technology: membrane selection and patient outcome, NEPH DIAL T, 15(8), 2000, pp. 1133-1139
Authors:
Valderrabano, F
Horl, WH
Jacobs, C
Macdougall, IC
Citation: F. Valderrabano et al., European Survey on Anaemia Management (ESAM) - Foreword, NEPH DIAL T, 15, 2000, pp. 1-1
Authors:
Valderrabano, F
Horl, WH
Jacobs, C
Macdougall, IC
Parrondo, I
Manhaeve, D
Milisen, K
Citation: F. Valderrabano et al., European Survey on Anaemia Management (ESAM) - Patients and methods, NEPH DIAL T, 15, 2000, pp. 2-7
Authors:
Valderrabano, F
Horl, WH
Jacobs, C
Macdougall, IC
Parrondo, I
Cremers, S
Abraham, IL
Citation: F. Valderrabano et al., European Best Practice Guidelines 1-4 - Evaluating anaemia and initiating treatment, NEPH DIAL T, 15, 2000, pp. 8-14
Authors:
Jacobs, C
Horl, WH
Macdougall, IC
Valderrabano, F
Parrondo, I
Segner, A
Abraham, IL
Citation: C. Jacobs et al., European Best Practice Guidelines 5 - Target haemoglobin, NEPH DIAL T, 15, 2000, pp. 15-19
Authors:
Macdougall, IC
Horl, WH
Jacobs, C
Valderrabano, F
Parrondo, I
Thompson, K
Cremers, S
Citation: Ic. Macdougall et al., European Best Practice Guidelines 6-8 - Assessing and optimizing iron stores, NEPH DIAL T, 15, 2000, pp. 20-32
Authors:
Jacobs, C
Horl, WH
Macdougall, IC
Valderrabano, F
Parrondo, I
Abraham, IL
Segner, A
Citation: C. Jacobs et al., European Best Practice Guidelines 9-13 - Anaemia management, NEPH DIAL T, 15, 2000, pp. 33-42
Authors:
Horl, WH
Jacobs, C
Macdougall, IC
Valderrabano, F
Parrondo, I
Thompson, K
Carveth, BG
Citation: Wh. Horl et al., European Best Practice Guidelines 14-16 - Inadequate response to epoetin, NEPH DIAL T, 15, 2000, pp. 43-50
Authors:
Horl, WH
Jacobs, C
Macdougall, IC
Valderrabano, F
Parrondo, I
Carveth, BG
Thompson, K
Citation: Wh. Horl et al., European Best Practice Guidelines 17-18 - Adverse effects, NEPH DIAL T, 15, 2000, pp. 51-56
Authors:
Valderrabano, F
Citation: F. Valderrabano, Quality of life benefits of early anaemia treatment, NEPH DIAL T, 15, 2000, pp. 23-28